Axsome Therapeutics, Inc. (FRA:19X)
Germany flag Germany · Delayed Price · Currency is EUR
129.20
+1.15 (0.90%)
Last updated: Dec 1, 2025, 8:05 AM CET

Axsome Therapeutics Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
6,5873,9613,4073,1341,2522,487
Upgrade
Market Cap Growth
46.92%16.24%8.72%150.30%-49.66%-26.64%
Upgrade
Enterprise Value
6,4953,8303,1983,0091,1952,361
Upgrade
Last Close Price
129.2070.0071.1870.6231.9166.10
Upgrade
PS Ratio
13.7710.6313.9266.94--
Upgrade
PB Ratio
104.8271.9219.7230.5791.1026.74
Upgrade
P/TBV Ratio
395.11-29.9784.6191.1026.74
Upgrade
EV/Sales Ratio
13.4210.2813.0664.28--
Upgrade
Debt / Equity Ratio
2.973.380.980.863.180.44
Upgrade
Asset Turnover
0.910.670.590.24--
Upgrade
Inventory Turnover
2.402.162.68---
Upgrade
Quick Ratio
1.451.993.462.473.757.85
Upgrade
Current Ratio
1.572.113.632.543.757.85
Upgrade
Return on Equity (ROE)
-275.50%-231.63%-159.21%-298.97%-201.51%-70.36%
Upgrade
Return on Assets (ROA)
-19.79%-27.28%-24.86%-52.30%-56.91%-30.46%
Upgrade
Return on Capital (ROIC)
-42.17%-50.30%-39.31%-81.33%-68.00%-34.16%
Upgrade
Return on Capital Employed (ROCE)
-63.10%-74.60%-40.70%-74.70%-192.70%-60.90%
Upgrade
Earnings Yield
-2.97%-7.00%-6.35%-5.59%-9.16%-3.38%
Upgrade
FCF Yield
-1.31%-3.14%-3.87%-3.50%-7.62%-2.58%
Upgrade
Buyback Yield / Dilution
-3.38%-5.48%-11.73%-8.07%-1.11%-9.37%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.